Document is current
Any future updates will be listed below
-
Authors
Casas-Arozamena, Carlos http://orcid.org/0000-0002-3279-2482
Vilar, Ana
Cueva, Juan
Arias, Efigenia
Sampayo, Victoria
Diaz, Eva
Oltra, Sara S
Moiola, Cristian Pablo
Cabrera, Silvia
Cortegoso, Alexandra
Curiel, Teresa
Abalo, Alicia
Pamies Serrano, Mónica
Domingo, Santiago
Padilla-Iserte, Pablo
Arnaez de la Cruz, Marta
Hernández, Alicia
García-Pineda, Virginia
Ruiz-Bañobre, Juan
López, Rafael
Matias-Guiu, Xavier
Colás, Eva
Gil-Moreno, Antonio
Abal, Miguel
Moreno-Bueno, Gema
Muinelo-Romay, Laura
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI20/00969, PI20/01566, PI21/00990, AC21_2/00020, Miguel Servet (CP20/00119), Miguel Servet (CP22/00147), Juan Rodés (JR21/00019))
Ministerio de Ciencia e Innovación (PID2022-136854OB-I00)
Centro de Investigación Biomédica en Red de Cáncer (CB16/12/00328, CB16/12/00295)
Fundación Científica Asociación Española Contra el Cáncer (FCAECC, GCTRA1804MATI, FCAECC-postdoctoral (PI21/00990))
Xunta de Galicia (IN607D2021/05)
Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS-predoctoral grant)
- License Information
-
More Information
Article History
Received: 9 June 2024
Accepted: 8 August 2024
First Online: 20 September 2024
Declarations
:
: The study was approved by the corresponding Research Ethics Committees (Galician Research Ethics Committee—reference number 2017/530 and 2022/029, Vall d’Hebron Research Ethics Committee—reference number PRAMI276-2018) and conducted in accordance with the guidelines for Good Clinical Practice and the Declaration of Helsinki. All patients provided written informed consent before enrolment.
: All patients provided written informed consent before enrolment.
: Authors declare no conflict of interest.
